Skip to main content

Table 1 Characteristics of the study group

From: Stereotactic radiotherapy is a useful treatment option for patients with medullary thyroid cancer

Patient

sex

age

pT

pN

M

target

Treatment method

Treatment date

Fractionated

Dose [Gy]

Total dose [Gy]

Follow-up

[years]

1.

m

56

2

1

LN, bones,

lungs

Th1

Th10

CK

CK

2012,

2018

10

6

10

18

7

1

2.

f

44

x

1

bones

Th7

L4

CK

CK

2016

2016

10

10

30

30

3

3

3.

f

65

x

1

bones

Th8

ST

 

10

10

8

4.

f

75

x

1

LN, bones

liver

Liver

ST-G

2019

12

12

1

5.

f

39

2

0

bones, liver

L4

Th2

CK

CK

2012

2011

8

8

16

16

8

9

6.

f

60

3

1

bones,

liver

Skull

Liver

CK

CK

2012

2012

10

8

10

8

1

1

7.

f

65

x

1

LN,

liver

LN

CK

2018

8

24

1

8.

m

44

4

1

bones

Th6

L1

CK

CK

2013

2013

7

10

21

20

1

1

9.

f

62

4

1

Lungs, local recurrence

Recurrence

St

2006

8

8

2

10.

m

24

1

0

0

Primary thyroid tumor

St

2017

12

36

1

11.

m

50

3

1

Retropharyngeal

LN

LN

CK

2016

5

45

3

  1. LN lymph nodes, CK cyber knife, St Stereotactic radiotherapy